secwatch / observer

8-K/A filed July 12, 2024, 7:59 PM ET ticker CNSP CIK 0001729427

regulatory confidence high sentiment neutral materiality 0.55

CNS Pharma regains Nasdaq bid price compliance; still faces equity rule delisting risk

CNS Pharmaceuticals, Inc.

Received Nasdaq letter on July 5, 2024 confirming bid price compliance (closing bid >=$1.00 for 20 consecutive business days through July 3).
Previously granted extension until July 15, 2024 to demonstrate compliance with both Bid Price and Equity Rules.
Company still not compliant with $2,500,000 stockholders' equity requirement (Nasdaq Listing Rule 5550(b)); further updates expected.
Delisting risk remains if equity compliance not demonstrated by deadline.

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001683168-24-004772
form_type: 8-K/A
ticker: CNSP
cik: 0001729427
company_name: CNS Pharmaceuticals, Inc.
filed_at: 2024-07-12T23:59:59+00:00
discovered_at: 2026-05-14T18:03:14.335123+00:00
generated_at: 2026-05-31T21:11:08.734437+00:00
sec_items: ["8.01"]
event_type: regulatory
sentiment: neutral
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001683168-24-004772
json_url: https://secwatch.observer/filing/0001683168-24-004772.json
markdown_url: https://secwatch.observer/filing/0001683168-24-004772.md
text_url: https://secwatch.observer/filing/0001683168-24-004772.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1729427/000168316824004772/0001683168-24-004772-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1729427/000168316824004772/cns_8ka.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

LESL

Leslie's regains Nasdaq compliance for minimum market value of publicly held shares

Leslie's, Inc. June 1, 2026, 4:28 PM ET regulatory Items 8.01

same SEC item: 8.01 same event type: regulatory similar materiality

Filing page SEC filing

RICK

RCI Hospitality regains Nasdaq compliance after filing delayed Q1 10-Q

RCI HOSPITALITY HOLDINGS, INC. June 1, 2026, 3:08 PM ET regulatory Items 8.01, 9.01

same SEC item: 8.01 same event type: regulatory similar materiality

Filing page SEC filing

VYGR

FDA clears IND for VY1706, Voyager's tau-silencing gene therapy for Alzheimer's

Voyager Therapeutics, Inc. June 1, 2026, 8:00 AM ET regulatory Items 8.01

same SEC item: 8.01 same event type: regulatory similar materiality

Filing page SEC filing

EXFY

Expensify regains Nasdaq minimum bid price compliance

Expensify, Inc. May 29, 2026, 5:15 PM ET regulatory Items 8.01

same SEC item: 8.01 same event type: regulatory similar materiality

Filing page SEC filing

SLXN

Silexion Therapeutics completes 1-for-10 reverse share split; warrants adjusted

Silexion Therapeutics Corp May 29, 2026, 7:00 AM ET regulatory Items 3.03, 5.03, 8.01, 9.01

same SEC item: 8.01 same event type: regulatory similar materiality

Filing page SEC filing

MNKD

FDA releases MannKind from Afrezza malignancy study; sBLA for children PDUFA May 29

MANNKIND CORP May 28, 2026, 8:37 AM ET regulatory Items 8.01

same SEC item: 8.01 same event type: regulatory similar materiality

Filing page SEC filing

SNAL

Snail receives Nasdaq extension to Sept 22, 2026 to regain listing compliance

Snail, Inc. May 27, 2026, 4:25 PM ET regulatory Items 8.01

same SEC item: 8.01 same event type: regulatory similar materiality

Filing page SEC filing

JAGX

Jaguar Health regains Nasdaq Bid Price compliance; monitoring until May 2027

Jaguar Health, Inc. May 27, 2026, 9:10 AM ET regulatory Items 7.01, 8.01, 9.01

same SEC item: 8.01 same event type: regulatory similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001683168-24-004772

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.